It is time to reconsider the risks of transfusing RhD negative females of childbearing potential with RhD positive red blood cells in bleeding emergencies-Reference-Cited by-同舟云学术

It is time to reconsider the risks of transfusing RhD negative females of childbearing potential with RhD positive red blood cells in bleeding emergencies

Published:2019-10-18 Issue:12 Volume:59 Page:3794-3799
ISSN:0041-1132
Container-title:Transfusion
language:en
Short-container-title:Transfusion

Author:

Yazer Mark H.¹²^ORCID,Delaney Meghan³⁴,Doughty Heidi⁵,Dunbar Nancy M.⁶^ORCID,Al‐Riyami Arwa Z.⁷^ORCID,Triulzi Darrell J.¹²,Watchko Jon F.⁸,Wood Erica M.⁹¹⁰,Yahalom Vered¹¹,Emery Stephen P.¹²

Affiliation:

1. Department of PathologyUniversity of Pittsburgh Pittsburgh Pennsylvania

2. Vitalant Pittsburgh Pennsylvania

3. Division of Pathology and Laboratory MedicineChildren's National Medical Center Washington District of Columbia

4. Department of Pathology and PediatricsGeorge Washington University Medical School Washington District of Columbia

5. NHS Blood and Transfusion Birmingham UK

6. Department of Pathology and Laboratory MedicineDartmouth‐Hitchcock Medical Center Lebanon New Hampshire

7. Department of HematologySultan Qaboos University Hospital Muscat Oman

8. Department of PediatricsUniversity of Pittsburgh School of Medicine Pittsburgh Pennsylvania

9. Transfusion Research UnitSchool of Public Health and Preventive Medicine, Monash University Melbourne Australia

10. Department of Clinical HaematologyMonash Health Melbourne Australia

11. Rabin Medical CenterBlood Services and Apheresis Institute Petah Tiqva Israel

12. Department of Obstetrics, Gynecology and Reproductive SciencesUniversity of Pittsburgh School of Medicine Pittsburgh Pennsylvania

Publisher

Wiley

Subject

Hematology,Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/trf.15569

Reference46 articles.

1. AABB Association Bulletin #19‐02. Recommendations on the Use of Group O Red Blood Cells.2019.

2. Blood Group Antigen Matching Influence on Gestational Outcomes (AMIGO) study

3. The management of Rh‐Isoimmunization;Bowman JM;Obstet Gynecol,1978

4. Middle Cerebral Artery Peak Systolic Velocity

5. The near disappearance of fetal hydrops in relation to current state-of-the-art management of red cell alloimmunization

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. RhD-Alloimmunization in Adult and Pediatric Trauma Patients;Transfusion Medicine Reviews;2024-10

2. Survey of pediatric massive transfusion protocol practice at United States level I trauma centers: An AABB Pediatric Transfusion Medicine Subsection study;Transfusion;2024-09-08

3. ASIAN TYPE DEL: TESTS FOR RED CELLS AND MANAGEMENTS FOR RECIPIENTS, DONORS, AND PREGNANT/POTENTIAL CHILDBEARING WOMEN;Japanese Journal of Transfusion and Cell Therapy;2024-08-26

4. Optimizing O red blood cell concentrate usage in the emergency department in the era of patient blood management;Hematology, Transfusion and Cell Therapy;2024-08

5. A review of attitudes to urgent RhD‐positive transfusions in female patients and the risk for hemolytic disease of the fetus and newborn;Transfusion;2024-07-23